RJ

Rakesh Jambuprasad Agrawal

Active Director Managing Director DIN 01483551
DIN 01483551 First appointment Feb 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2000
Shareholding value •••• Premium profile

About Rakesh Jambuprasad Agrawal

Data last updated:

Rakesh Jambuprasad Agrawal is a Managing Director at Medoz Pharmaceuticals Private Limited (since 2000). The company operates in Pharma. Medoz Pharmaceuticals Private Limited reported revenue of ₹13.36 Cr (FY 2025).

DIN 01483551
Primary Designation Managing Director
Industry Pharma
First Appointment 02 Feb 2000
Oldest Company Age 26 yrs
Largest company Medoz Pharmaceuticals Private Limited · ₹13.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director02 Feb 20002000₹13.36 Cr (FY 2025)Active

Board colleagues of Rakesh Jambuprasad Agrawal

NameDINCompanyDesignation
Parmar Rameshkumar08565021Medoz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medoz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Jambuprasad Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Jambuprasad Agrawal

Rakesh Jambuprasad Agrawal currently holds 1 directorship: Medoz Pharmaceuticals Private Limited (Managing Director, since 02 Feb 2000, revenue ₹13.36 Cr (FY 2025)).

Rakesh Jambuprasad Agrawal was first appointed on 02 Feb 2000 as Managing Director at Medoz Pharmaceuticals Private Limited.

The current boards of Rakesh Jambuprasad Agrawal's companies include Parmar Rameshkumar (Medoz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available